Biblio

[ Author(Asc)] Title Type Year
Filters: Author is Wang, Ling  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Wang L, Wang Y, Tang W, Dou H-B, Shan J-H, Hu J. The superiority of allogeneic hematopoietic stem cell transplantation from unrelated donor over chemotherapy for adult patients with high-risk acute lymphoblastic leukemia in first remission. Int J Hematol. 2013.
Wang L, González S, Dai W, Deng S, Lu L. Effect of Hypoxia-regulated Plk3 On Human Limbal Stem Cell Differentiation. J Biol Chem. 2016.
Wang L, Deng K, Gong L, Zhou L, Sayed S, Li H, Sun Q, Su Z, Wang Z, Liu S, et al. Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity. Pharmacol Res. 2020:104955.
Wang L, Kuang Z, Zhang D, Gao Y, Ying M, Wang T. Reactive oxygen species in immune cells: A new antitumor target. Biomed Pharmacother. 2020;133:110978.
Wang L, Zeng Y-Q, Gu J-H, Song R, Cang P-H, Xu Y-X, Shao X-X, Pu L-J, Luo H-Y, Zhou X-F. Novel oral edaravone attenuates diastolic dysfunction of diabetic cardiomyopathy by activating the Nrf2 signaling pathway. Eur J Pharmacol. 2022:174846.
Wang L, Watters JW, Ju X, Lu G, Liu S. Head-on and co-directional RNA polymerase collisions orchestrate bidirectional transcription termination. Mol Cell. 2023.
Wang L, Chen P, Pan Y, Wang Z, Xu J, Wu X, Yang Q, Long M, Liu S, Huang W, et al. Injectable photocurable Janus hydrogel delivering hiPSC cardiomyocyte-derived exosome for post-heart surgery adhesion reduction. Sci Adv. 2023;9(31):eadh1753.
Wang L, Liu S, Li K, Ma A, Hu C, Wang C, Cao N, Zhao Y, Fu R, Jia W, et al. General requirements for the production of extracellular vesicles derived from human stem cells. Cell Prolif. 2023:e13554.
Wang L, Zeng Q, Wang S, Wu D, Wang J, Zhang H, Lv X. Establishment of an induced pluripotent stem cell line (SDCHi001-A) from a healthy Chinese child donor. Stem Cell Res. 2023;74:103278.
Wang L, Liang Z, Guo Y, Habimana Jde Dieu, Ren Y, Amissah OBoadi, Mukama O, Peng S, Ding X, Lv L, et al. STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells. Cell Death Dis. 2024;15(4):265.